AI-derived biomarker assesses cardiovascular health, suggesting early intervention and personalized monitoring with wearable devices.
AI-PPG age is a scalable, non-invasive biomarker for cardiovascular health assessment. Integrated with wearable devices, it may enable population-level screening, personalized monitoring, and early intervention.
No takes yet. Share an insight, caveat, or question.
Nie et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: